tigecycline
tigecycline is a pharmaceutical drug with 45 clinical trials. Currently 2 active trials ongoing. Historical success rate of 93.9%.
Success Metrics
Based on 31 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
5
Mid Stage
27
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.1%
31 of 36 finished
13.9%
5 ended early
2
trials recruiting
45
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline
Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
Clinical Trials (45)
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline
Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
Antibiotic Therapy for Infectious Diseases
A Randomized Controlled Trial Comparing Imipenem and Tigecycline Versus Imipenem and Tigecycline With GM-CSF for the Management of Spontaneous Bacterial Peritonitis Presenting With Septic Shock.
Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae
The Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae
A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)
Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)
A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection
Tigecycline for Treatment of Rapidly Growing Mycobacteria
Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects
Study of Tigecycline Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy(CRRT)
Impact of Treatment With Colistin on Mortality Bacteremia Multiresistant Acinetobacter Baumannii Sensitive Colistin in Patients Critical
Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia
Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 45